H.C. Wainwright’s Mitchell Kapoor maintained Halozyme Therapeutics Inc. (NASDAQ:HALO) at a $72 price target and a Buy rating ...

The European Commission (EC) has approved a new Opdivo (nivolumab) formulation associated with a new route of administration ...

Bristol Myers Squibb receives European approval for subcutaneous formulation of Opdivo across multiple solid tumour indications: Princeton, New Jersey Thursday, May 29, 2025, 15:0 ...

The EC has granted approval for the new subcutaneous (SC) formulation of Bristol Myers Squibb’s (BMS) Opdivo (nivolumab) ...

Bristol Myers on Wednesday said the European Commission approved the subcutaneous formulation of Opdivo for use across multiple adult solid tumors as monotherapy, monotherapy maintenance following ...

Bristol Myers Squibb Canada (BMS) today announced that Health Canada has approved OPDIVO® SC (nivolumab for subcutaneous injection) across all currently authorized solid tumour indications in ...

Market LaunchFormycon and Fresenius Kabi announce the commercial launch of FYB202/Otulfi™, an approved ustekinumab biosimilar in Canada 27.05.2025 / 14:30 CET/CESTThe issuer is solely responsible for ...

A drug, Keytruda, one of the world's most effective cancer medications, promises to transform treatment by delivering ...

In a major breakthrough for haemophilia care, the National Institute for Health and Care Excellence (NICE) has issued final ...

Chinese artificial intelligence (AI) model DeepSeek passed the gastroenterology board examination, with scores of 77.1% to 81.5%, outperforming legacy ChatGPT models. (American Journal of ...